期刊文献+

膀胱移行细胞癌患者尿脱落细胞中MUC7和CK20的表达及其临床意义 被引量:3

Muc7and CK20 expression in exfoliated urothelial cells of the urine in patients with bladder cancer.
下载PDF
导出
摘要 目的探讨MUC7和CK20在膀胱移行细胞癌(BTCC)患者尿脱落细胞中的表达及其临床意义。方法采用逆转录聚合酶链反应(RT-PCR)检测42例BTCC患者、40例对照者尿脱落细胞中MUC7和CK20 mRNA表达。结果42例BTCC患者中36例尿脱落细胞中MUC7表达阳性,34例CK20表达阳性,阳性率分别为85.7%和80.9%,40例对照组中有2例MUC7表达阳性,有12例CK20表达阳性,阳性率分别为5.0%和30%;两者诊断敏感性的差异无显著性(P>0.05);两者的诊断特异性分别为95%和70%,MUC7的诊断特异性显著优于CK20(P<0.01)。浸润性BTCC其MUC7的阳性表达率显著高于浅表性BTCC(P<0.05),而CK20在不同临床分期的肿瘤中差异无显著性(P>0.05)。MUC7的表达与BTCC的病理分级呈正相关,CK20的表达在各病理分级间差异无显著性。结论BTCC患者尿脱落细胞中MUC7的阳性表达率明显高于CK20和对照组,尿脱落细胞中MUC7表达与BTCC的临床分期、病理分级有关,而CK20的表达与分期、分级无相关性。 Objective This paper is aimed to study whether it can provide a novel noninvasive tool for the diagnosis of bladder transtional cell carcinoma BTCC the bladder by detection of Muc7 and Ck20 expression in urine using RT-PCR. Methods The morning urine samples of 42 patients with BTCC ,40 persons in control group were collected The expression of MucT,Ck20 and β-actin in exfoliated urinary cells were determined by using RT-PCR.Results Only 2 of 40(5.0% )and 12 of 40(30% ) showed positive expression of MUC7 and CK20 expression in control group. 36 of 42(85.7 % )patients with BTCC showed a positive MUC7 expression and 34 of 42 (80.9 %)showed a positive CK20 expression in urine. The sensitivity in detecting MUC7 and CK20 expression for diagnosis of BTCC is 85.7 % and 80.9%, respectively. Higher specificity was observed in MUG7 expression detection than that in CK20 (95 % vs 70%, P 〈 0.01). Respectively indicated that expression of MUC7 had a positive correlation with the increasing stage of BTCC, But Ck20 expression hadn't this correlation, the expression of MUC7 was positively correlated with the pathologic grading of BTCC while no significant difference was founded in CK20 expression. Conclusion the positive expression rate of MUC7 and CK20 in exfoliated urothclial cell of urine in patients with BTCC is 85.7 % and 80.9 %, respectively, which is significantly higher than that in control group( 5 % and 30 % ) ;MUC7 expression is positively correlated with the staging and grading of BTCC, while CK20 has no this correlation.
出处 《四川医学》 CAS 2006年第6期558-560,共3页 Sichuan Medical Journal
关键词 膀胱肿瘤 MUC7 CK20 逆转录聚合酶链反应 尿脱落细胞 Bladder transitional cell carcinoma MUC7 Ck20 reverse transcriptase-polymerase chain reaction exfoliated urothelial cell of urine
  • 相关文献

参考文献14

  • 1Droller M J.Bladder cancer : state of the art cancer[ J ]. CA Cancer J Clin,1998,48(5):269 - 284
  • 2Grossman HB.New methods for detection of baldder cancer[J]. Semin Urol Oncol, 1998,16( 1 ) : 17 - 22
  • 3Ramakumar S,Bhuiyan J, Besse JA, et al.Comparison of Screening methods in the detection of bladder cancer[J].J Urol, 1999,161(2):388 - 394
  • 4Brown FM. Urine cytology: it is stilhhe gold standard for screening[J]. Urol Clin North Am,2000,27(2) :25 - 37
  • 5Coulombe PA, The cellular and molecular biology of keratins: beginning a nwe era[J]. Curr Opin Cell Bol, 1993,5(4) : 17 - 29
  • 6Lesuffeur T, Zweibanm A,Real FX. Mucins in normal and neoplastic human gastrointestinal tissues[J]. Grit Rev Oncel Hematol, 1994, 17 ( 1 ) : 153-180
  • 7Hansk L, Hofmeier M, Schmitt-Graff A, et al.Over expression or ectopic expression of Muc2 is the common property of mucinous carcinomas of the colon,pancreas,bream,and ovary[J] .J Pathol, 1997,182(5):385 - 391
  • 8Huben RP.Tumor markers in bladder cancer[J] .Urolgy, 1984,23(3 Suppl) : 10 - 14
  • 9Klein A,Zemer R, Baehumensky V, et al.Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma[J]. Am Cancer, 1998,82(2) :349 - 354
  • 10Buehumensky V, Klein A, Zemer R. Cytokeratin 20 : a new marker for early detection of bladder cell carcinoma[J] .J Urol, 1998,160(3) : 1971 - 1974

二级参考文献10

  • 1Moll R,Lowe A,Laufer J,et al.Cytokeratin 20 in human carcinomas-a new histodiagnositic marker.Am J Pathol,1992,140:427- 447.
  • 2Harnden P,Eardley I,Joyce A.D,et al.Cytokeratin 20 as an objective marker of urothelial dysplasia.Br J Urol,1996,78:870-875.
  • 3Klein A,Zemer R,Buchumensky V,et al.Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.Am Cancer,1998,82:349-354.
  • 4Harnden P,Mahmood N,Southgate J.Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.Lancet ,1999,353:9157.
  • 5Moll R,Lowe A,Lanfer J,et al.Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies[].American Journal of Pathology.1992
  • 6Moll R,Schiller DL,Franke WW,et al.Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression pattern[].The Journal of Cell Biology.1990
  • 7Chandler JS,Calnnek D,Quaroni A.Identification and characterization of rat intestinal keratins[].Journal of Biological Chemistry.1991
  • 8Burchill SA,Bradbury MF,Pittman K,et al.Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction[].British Journal of Cancer.1995
  • 9Buchumensky V,Klein A,Zemer R,et al.Cytokeratin 20: a new marker for early detection of bladder cell carcinoma[].Journal d Urologie.1998
  • 10刘冉.细胞角蛋白20及其在肿瘤诊断中的应用[J].国外医学(肿瘤学分册),1998,25(1):14-16. 被引量:4

共引文献10

同被引文献6

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部